Est. 2001·3,000+ placements · six offices · four regions

Company signals · MedTech

Perimeter Medical Imaging AI, Inc.

1 signal in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: Backdrop: a 122.7 (Hot) Talent Market Index (up 17.8 on the month) with Americas activity rising (+34.4pts).

Perimeter Medical Imaging AI, Inc.: 0 signals in the last 90 days — below the MedTech median of 1 across 18 tracked companies.

Signals at Perimeter Medical Imaging AI, Inc.

Capital Raising

Americas

Perimeter Medical Imaging AI filed Form D for private placement, indicating capital raising activity

Leadership read: Perimeter Medical Imaging AI's Form D filing commits the company to a formal private placement process, which is a materially different operating posture than pre-raise. A Form D filing means securities have already been sold; this is not a fundraising intent; capital has transferred. For a company whose core proposition sits at the intersection of real-time intraoperative imaging and AI-assisted margin assessment, fresh capital almost certainly ties to one of three hard operational commitments: clinical-site expansion to generate the regulatory-grade evidence the FDA pathway requires, a build-out of the commercial infrastructure needed to move from early adopter hospitals to scalable health system contracts, or both simultaneously. This is one of twelve capital-raising signals we have tracked across AI and medtech in the last 90 days. The set is wide, fusion energy, compute infrastructure, cybersecurity, but the medtech-adjacent cluster is the more instructive comparator. EVERSION Technologies' €2.3M Seed II for AI-powered surgical correction tooling maps to the same underlying dynamic: capital entering AI-assisted clinical hardware at the moment regulatory and reimbursement clarity starts to firm up. That is the consistent pattern: private rounds clustering around the proof-to-commercial inflection, not the ideation stage. Companies reaching this stage in AI-assisted surgical and diagnostic imaging consistently face concentrated demand in three functional areas: regulatory affairs leadership with FDA 510(k) and De Novo experience, clinical commercial teams who can sell into hospital procurement and OR committees simultaneously, and health-economics capability that builds the reimbursement case running parallel to the clinical one. The market is moving toward operators who can compress the distance between regulatory clearance and contracted revenue.

curated · 2026-06-03 · context →

More signals across MedTech

Capital Raising · Americas

HistoSonics →

HistoSonics, a developer of non-invasive cancer treatment using focused ultrasound (histotripsy technology), secured funding from MPower Partners Fund II and strategic investors including Yosemite. Amount undisclosed.

Partnership · Americas

CMR Surgical →

CMR Surgical and Stryker have formed a strategic alliance granting Stryker an exclusive US commercial agency for the Versius surgical robot portfolio, with CMR retaining commercialisation outside the US.

Leadership Change · Americas

Boston Scientific Corporation →

Boston Scientific appoints Joseph M. Fitzgerald as Executive Vice President and Chief Operating Officer, supported by new operating structure designed to increase efficiency and support continued growth.

Product Launch · Americas

Edwards Lifesciences →

Edwards Lifesciences received FDA approval for Autus, an expandable pulmonary valve designed for pediatric patients. This is the first FDA-approved heart valve designed to expand post-surgery to accommodate a child's growth.

Leadership Change · Americas

Owens & Minor →

Owens & Minor appointed Carrie Childress as its first Chief Marketing Officer in company history. Childress brings nearly 20 years of healthcare marketing, product management, and brand development experience.

Product Launch · Americas

Cerapedics Inc. →

PearlMatrix P-15 Peptide Enhanced Bone Graft received Medicare New Technology Add-on Payment (NTAP), enabling hospitals to claim additional reimbursement for lumbar fusion procedures using the product.

Where Perimeter Medical Imaging AI, Inc.'s market lands in our work

Weekly briefing

Track companies like Perimeter Medical Imaging AI, Inc. — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

MitchelLake is a global executive search and advisory firm covering AI, innovation and expansion leadership for companies navigating transformation and change across industries, from startups and scale-ups to private-equity-backed and enterprise organisations. 3,000+ C-suite, specialist and board placements since 2001.

Discuss leadership at a moment like this →
Data period
3 Jun 2026 – 3 Jun 2026 · 1 signals for this company
Publisher
MitchelLake

Last updated